BIOTRONIK
BIOTRONIK's Overview
BIOTRONIK is a leading global medical technology company with a rich history of innovation in cardiovascular and endovascular solutions. Founded in 1963 in Germany, the company develops and manufactures a comprehensive portfolio of products including pacemakers, implantable defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, stents, catheters, and remote patient monitoring systems. BIOTRONIK is dedicated to improving patient lives by providing physicians with high-quality, reliable, and clinically-proven medical technologies. The company has a strong focus on research and development, striving to create therapies that save and enhance the quality of life for patients suffering from heart and blood vessel diseases.
Where is BIOTRONIK's Headquarters?
HQ Function
The Berlin headquarters houses global corporate management, strategic decision-making, core administrative functions, and significant research and development activities for select product lines. It coordinates BIOTRONIK's global operations.
Notable Features:
The campus features modern office buildings and advanced research and development laboratories designed to foster collaboration and innovation in medical technology. Specific architectural highlights are not widely publicized, but functionality and efficiency are key.
Work Culture:
BIOTRONIK's work culture at its Berlin HQ is characterized by its German engineering heritage, emphasizing precision, quality, and innovation. It fosters a collaborative environment focused on developing life-saving medical technologies, with a strong commitment to scientific excellence and employee development.
HQ Significance:
The Berlin headquarters is pivotal to BIOTRONIK's identity as a global leader in medical technology. It underscores its German roots, commitment to high-quality engineering, and serves as the command center for its international R&D, manufacturing, and commercial strategies.
Values Reflected in HQ: The headquarters reflects BIOTRONIK's core values of excellence, innovation, quality, and reliability. Its focus on advanced R&D facilities and efficient operations mirrors the company's dedication to creating superior medical solutions for patient care.
Location:
BIOTRONIK operates on a global scale, with a direct presence in numerous countries and distribution partners in over 100 nations. Key functions supported globally include research and development (with major hubs in Germany, Switzerland, USA, and Singapore), advanced manufacturing, international sales and marketing, comprehensive clinical support and training for healthcare professionals, technical services, and regulatory affairs tailored to local market requirements. This extensive network ensures that BIOTRONIK's life-saving medical technologies reach patients worldwide.
Street Address:
Woermannkehre 1
City:
Berlin
State/Province:
Berlin
Country:
Germany
BIOTRONIK's Global Presence
Lake Oswego, Oregon/USA
Address: 6024 Jean Road, Lake Oswego, OR 97035, USA
To effectively manage and grow BIOTRONIK's presence in the critical U.S. medical device market, ensuring compliance with FDA regulations and tailoring solutions to meet the needs of U.S. healthcare providers and patients.
Bülach, Zurich/Switzerland
Address: Schaffhauserstrasse 131, 8180 Bülach, Switzerland (Major operations/manufacturing site)
Functions as a crucial center for innovation and high-quality production within BIOTRONIK's global network, supplying advanced cardiac devices to European and international markets.
Singapore/Singapore
Address: 10 Eunos Road 8, #13-08 Singapore Post Centre, Singapore 408600 (Regional HQ Office); Manufacturing also present in Singapore.
To spearhead BIOTRONIK's growth in the dynamic Asia-Pacific healthcare markets, adapt global strategies to regional needs, and utilize Singapore's status as a key biomedical and logistics hub.
Buying Intent Signals for BIOTRONIK
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of BIOTRONIK
As of April 2025, BIOTRONIK' leadership includes:
Investors of BIOTRONIK
BIOTRONIK has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
BIOTRONIK, as a privately held company, maintains a relatively stable executive leadership team and does not frequently publicize all executive movements. No major (Group CEO/CFO level) leadership changes have been broadly announced in the last 12 months (as of mid-2024). Changes at divisional or regional executive levels may occur but are typically not subjects of widespread press releases.
Technology (Tech Stack) used by BIOTRONIK
Discover the tools BIOTRONIK uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BIOTRONIK Email Formats and Examples
BIOTRONIK commonly uses a standard email format for its employees. The most prevalent structure is `firstname.lastname@biotronik.com`. Another possible, though less common, format could be `firstinitiallast@biotronik.com`.
firstname.lastname@biotronik.com (e.g., john.doe@biotronik.com) or less commonly [first_initial][last]@biotronik.com (e.g., jdoe@biotronik.com)
Format
example.person@biotronik.com
Example
80%
Success rate
News and media
BIOTRONIK Newsroom • February 28, 2024
BIOTRONIK Announces U.S. Launch of Freesolve™ Resorbable Magnesium Scaffold for Below-the-Knee Artery Disease
BIOTRONIK has announced the U.S. launch of its Freesolve™ resorbable magnesium scaffold (RMS) following U.S. Food and Drug Administration (FDA) approval. This innovative device is indicated for patients suffering from chronic limb-threatening ischemia (CLTI) due to below-the-knee (BTK) artery disease, offering a new treatment option that resorbs over time....more
BIOTRONIK Newsroom • January 9, 2024
BIOTRONIK Announces FDA Approval and Launch of Amvia Sky™/Amvia Edge™ ICDs and CRT-Ds with ProMRI® Technology
BIOTRONIK announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of its latest generation of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), the Amvia Sky™ and Amvia Edge™ series. These devices feature ProMRI® technology, extended battery longevity, and advanced capabilities for early detection of silent atrial fibrillation....more
BIOTRONIK Newsroom • November 13, 2023
BIOTRONIK Receives FDA Approval for BIOMONITOR IV, the First Injectable Cardiac Monitor with Up to 8.5-Year Battery Longevity
BIOTRONIK announced it has received U.S. Food and Drug Administration (FDA) approval for its BIOMONITOR IV injectable cardiac monitor (ICM). This device is notable for its extended battery longevity of up to 8.5 years and its AI-powered SmartECG technology, enhancing diagnostic accuracy for long-term cardiac monitoring....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including BIOTRONIK, are just a search away.